Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;129(3):421-426.
doi: 10.1016/j.radonc.2018.05.030. Epub 2018 Jun 12.

Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?

Affiliations
Review

Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?

Reid F Thompson et al. Radiother Oncol. 2018 Dec.

Abstract

Artificial intelligence (AI) is emerging as a technology with the power to transform established industries, and with applications from automated manufacturing to advertising and facial recognition to fully autonomous transportation. Advances in each of these domains have led some to call AI the "fourth" industrial revolution [1]. In healthcare, AI is emerging as both a productive and disruptive force across many disciplines. This is perhaps most evident in Diagnostic Radiology and Pathology, specialties largely built around the processing and complex interpretation of medical images, where the role of AI is increasingly seen as both a boon and a threat. In Radiation Oncology as well, AI seems poised to reshape the specialty in significant ways, though the impact of AI has been relatively limited at present, and may rightly seem more distant to many, given the predominantly interpersonal and complex interventional nature of the specialty. In this overview, we will explore the current state and anticipated future impact of AI on Radiation Oncology, in detail, focusing on key topics from multiple stakeholder perspectives, as well as the role our specialty may play in helping to shape the future of AI within the larger spectrum of medicine.

Keywords: Artificial intelligence; Deep learning; Machine learning.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

WDL is the founder and CEO of Oncora Medical. CMC is the founder and CEO of Siris Medical, Inc.

References

    1. Hoagland J The fourth industrial revolution is upon us. The Washington Post; 2017.
    1. DeepMind. Applying machine learning to radiotherapy planning for head & neck cancer. (2016). Available at: https://deepmind.com/blog/applying-machine-learning-radiotherapy-plannin.... (Accessed: 1st January 2016)
    1. Valdes G et al. Clinical decision support of radiotherapy treatment planning: a data-driven machine learning strategy for patient-specific dosimetric decision making. Radiother Oncol 2017;125:392–7. 10.1016/j.radonc.2017.10.014. - DOI - PubMed
    1. Aljabar P, Gooding MJ. The cutting edge: delineating contours with Deep. Learning 2017.
    1. Oncora Medical. Available at: https://oncoramedical.com/. (Accessed: 1st November 2017)